
GLP-class & Metabolic
AOD-9604 Australia
- HPLC tested
- 99%+ purity
- COA on file · Janoshik
Free shipping over $100 · same-day dispatch before 12pm AEST · Australia only.
Supplied strictly for in-vitro / laboratory research use only. Not for human or animal consumption. You confirm you are 18+ and purchasing for research purposes.
Product details
AOD-9604 Australia. AOD-9604 is a synthetic peptide studied in laboratory research as a modified fragment of the C-terminal lipolytic domain of human growth hormone — the hGH(177-191) sequence with an added N-terminal tyrosine. The Elite AU Peptides AOD-9604 is independently HPLC-tested above 99% purity by Janoshik; the certificate of analysis is published on this page and in the lab-reports library, with the measured number — not a marketing figure — and an independently verifiable Janoshik key.
Stocked and dispatched AU-domestic in a 5 mg lyophilised vial, AUD pricing. Every batch is held until the independent HPLC report comes back within our acceptance threshold; nothing is listed without a certificate on file. Supplied strictly for in-vitro and laboratory research use only — not for human or animal consumption, not a therapeutic good, not TGA-approved.
- Form
- Lyophilised powder
- Sizes
- 5mg
- CAS number
- 221231-10-3
- Molecular formula
- C78H123N23O23S2
- Molecular weight
- 1815.1 g/mol
- Sequence
- YLRIVQCRSVEGSCGF
- Purity
- ≥ 99% (HPLC)
- Testing
- Janoshik — independent HPLC
- Storage
- Lyophilised −20°C; reconstituted 2–8°C
- Origin
- Dispatched AU-domestic, Australia-wide
- Use
- In-vitro / laboratory research only
AOD-9604 (CAS 221231-10-3; molecular formula C78H123N23O23S2, average molecular weight ≈ 1815 g/mol) is a 16-residue synthetic peptide — the sequence Tyr-hGH(177-191). It corresponds to the C-terminal lipolytic fragment of the human growth-hormone molecule, with an added N-terminal tyrosine; an intramolecular disulfide bridge between its two cysteine residues forms a small loop that mirrors the native hGH C-terminal loop. It is a distinct research entity from the intact 191-residue hormone.
In receptor and pathway research, AOD-9604 is studied as a probe of the growth-hormone lipolytic pathway that is structurally separable from the somatogenic, IGF-1-mediated actions of the intact hormone. The original metabolic characterisation of the synthetic fragment was reported by Ng and colleagues (Hormone Research, 2000), and Heffernan and colleagues (Endocrinology, 2001) used β3-adrenergic-receptor knock-out models to probe the pathway implicated in the fragment’s lipid-metabolic signalling — the reason the β3-adrenergic receptor is referenced across AOD-9604 research literature.
Because the peptide is a defined synthetic fragment, it is also studied as an analytical reference: Cox and colleagues (Drug Testing and Analysis, 2015) characterised its detection and in-vitro metabolic breakdown products. Together these give AOD-9604 a well-described identity in lipid-metabolism and growth-hormone-fragment research contexts.
The lipolytic activity of growth hormone was localised to its C-terminal region before AOD-9604 was designed; the peptide represents that domain as a discrete, disulfide-stabilised sequence, which is why it is used to study the lipid-metabolic signal in isolation from the hormone’s receptor-mediated growth axis. As a short, defined synthetic sequence it reconstitutes and stores predictably, making it a convenient reference compound for adipocyte and lipid-metabolism assays rather than a probe of the intact 191-residue hormone.
The information provided here is a research-reference summary only. Elite AU Peptides makes no medical, therapeutic, fat-loss, weight-loss, body-composition, or human-use claim about this product. AOD-9604 is not TGA-approved, is not a therapeutic good, and is supplied strictly for in-vitro and laboratory research use only. Researchers should consult the primary peer-reviewed literature for pathway data and protocol-specific reference values.
Reconstitute the lyophilised AOD-9604 vial with bacteriostatic water for laboratory handling. Add the diluent slowly down the vial wall and swirl gently rather than shaking. The required volume depends on your research protocol and target working concentration — a 5 mg vial reconstituted in 2 mL of bacteriostatic water yields a 2.5 mg/mL working stock.
Store the lyophilised powder at −20°C, desiccated and protected from light; once reconstituted, store refrigerated at 2–8°C and use within the documented research window, or aliquot and freeze to avoid repeated freeze-thaw cycles. Tamper-evident packaging; the batch label is the canonical reference for the certificate of analysis published in the lab-reports library.
Australia only. Free shipping over $100. Orders placed before 12pm AEST are dispatched the same business day from Australia.
30-day returns on unused product in original packaging, with prior approval.
- What is AOD-9604?
- AOD-9604 is a synthetic peptide — a modified fragment of the C-terminal lipolytic domain of human growth hormone (the hGH 177-191 sequence with an added N-terminal tyrosine) referenced in lipid-metabolism research literature. It is supplied strictly for in-vitro and laboratory research use only.
- Is AOD-9604 TGA-approved in Australia?
- No. AOD-9604 is not TGA-approved and is not a therapeutic good. We supply it strictly for in-vitro laboratory research use only and make no medical, fat-loss, weight-loss, body-composition, or human-use claim about this product.
- How is AOD-9604 tested?
- Every batch is independently HPLC-tested by Janoshik Analytical before listing. The certificate of analysis is published on this page and in the lab-reports library — real batch number, measured purity, independently verifiable at janoshik.com.
- Is this product third-party tested?
- Yes. Every batch is independently HPLC-tested by Janoshik, and the certificate of analysis is published on the lab-reports page.
- How should it be stored?
- Store the lyophilised powder at −20°C. Once reconstituted, keep it refrigerated at 2–8°C and use within the documented research window.
- How is it shipped?
- Dispatched AU-domestic from Australia. Free shipping over $100; orders placed before 12pm AEST are dispatched the same business day.
- What does 'research use only' mean?
- All products are supplied for in-vitro / laboratory research use only. They are not for human or animal consumption, are not therapeutic goods, and are not TGA-approved.
[ Further reading ]
AOD-9604 in Australia: a growth-hormone-fragment research guideWhat AOD-9604 is — a synthetic fragment of the C-terminal domain of human growth hormone — where it sits in lipid-metabolism-pathway research, and how research-grade material is HPLC-verified. Receptor/pathway framing only; a laboratory research reference for Australian researchers.
[ Certificate of analysis ]
Independently verified
Certificate of Analysis
- Lab
- Janoshik
- Batch / lot
- —
- Tested
- —
- Purity
- ≥ 99%
— The batch certificate and downloadable scan for AOD-9604 are published on the lab-reports page and confirmed at catalogue load.
Janoshik · HPLC
≥ 99%
brand standard · independently verified
[ Related products ]
Related research peptides



Elite AU Peptides supplies research peptides and related compounds for laboratory and in-vitro research use only. Products are not therapeutic goods, are not TGA-approved, and are not for human or animal consumption. Nothing on this site constitutes medical advice or a therapeutic claim. Purchasers must be 18 years or older and are responsible for complying with all applicable laws in their jurisdiction.